BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25196501)

  • 1. Studies on the prevalence of oncogenic HPV types among Lithuanian women with cervical pathology.
    Simanaviciene V; Gudleviciene Z; Popendikyte V; Dekaminaviciute D; Stumbryte A; Rubinaite V; Zvirbliene A
    J Med Virol; 2015 Mar; 87(3):461-71. PubMed ID: 25196501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
    Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
    J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type-specific prevalence in women referred for colposcopic examination in Beijing.
    Ding X; Liu Z; Su J; Yan D; Sun W; Zeng Z
    J Med Virol; 2014 Nov; 86(11):1937-43. PubMed ID: 25132373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.
    Nielsen A; Iftner T; Nørgaard M; Munk C; Junge J; Kjaer SK
    Sex Transm Infect; 2012 Dec; 88(8):627-32. PubMed ID: 22773328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests.
    Evans MF; Adamson CS; Schned LM; St John TL; Leiman G; Ashikaga T; Cooper K
    Diagn Mol Pathol; 2010 Sep; 19(3):144-50. PubMed ID: 20736743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.
    Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA
    J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevaccination distribution of human papillomavirus types in Italian women with high-risk lesions and cervical neoplasia.
    De Francesco MA; Gargiulo F; Schreiber C; Ciravolo G; Salinaro F; Manca N
    Intervirology; 2010; 53(6):417-25. PubMed ID: 20606464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of human papillomavirus genotypes in women with cervical alterations from north Argentina.
    Deluca GD; Marin HM; Blanco NS; Basiletti JA; González JV; Merino AL; Picconi MA
    Indian J Med Microbiol; 2013; 31(2):138-41. PubMed ID: 23867669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population.
    Magaña-Contreras M; Contreras-Paredes A; Chavez-Blanco A; Lizano M; De la Cruz-Hernandez Y; De la Cruz-Hernandez E
    J Med Virol; 2015 Dec; 87(12):2098-105. PubMed ID: 26010580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece.
    Kroupis C; Thomopoulou G; Papathomas TG; Vourlidis N; Lazaris AC
    Epidemiol Infect; 2007 Aug; 135(6):943-50. PubMed ID: 17553178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
    Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
    J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait.
    Al-Awadhi R; Chehadeh W; Jaragh M; Al-Shaheen A; Sharma P; Kapila K
    Diagn Cytopathol; 2013 Feb; 41(2):107-14. PubMed ID: 21987449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant human papillomavirus 16 infection in cervical neoplasia in young Japanese women; study of 881 outpatients.
    Masumoto N; Fujii T; Ishikawa M; Mukai M; Ono A; Iwata T; Kubushiro K; Nozawa S
    Gynecol Oncol; 2004 Aug; 94(2):509-14. PubMed ID: 15297196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?
    Kjær SK; Munk C; Junge J; Iftner T
    Cancer Causes Control; 2014 Feb; 25(2):179-89. PubMed ID: 24242002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
    Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
    J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.